With tweaks to gene therapy, Bluebird Bio makes progress in sickle cell – STAT
|
With tweaks to gene therapy, Bluebird Bio makes progress in sickle cell
STAT The new data show that Bluebird has been able to increase the number of gene-corrected cells taking hold in the bone marrow of sickle cell patients by improving the manufacturing process for its gene therapy, known as LentiGlobin. That suggests the … |
